Jupiter Life Line Hospitals Ltd
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap ₹ 10,096 Cr.
- Current Price ₹ 1,540
- High / Low ₹ 1,770 / 1,250
- Stock P/E 50.9
- Book Value ₹ 221
- Dividend Yield 0.07 %
- ROCE 18.0 %
- ROE 15.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 43.6% CAGR over last 5 years
Cons
- Stock is trading at 7.01 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 463 | 486 | 733 | 893 | 1,073 | 1,262 | 1,395 | |
| 379 | 419 | 580 | 691 | 831 | 965 | 1,070 | |
| Operating Profit | 84 | 67 | 153 | 201 | 242 | 297 | 325 |
| OPM % | 18% | 14% | 21% | 23% | 23% | 24% | 23% |
| 0 | 4 | 4 | 8 | 22 | 29 | 38 | |
| Interest | 26 | 39 | 44 | 42 | 26 | 11 | 24 |
| Depreciation | 26 | 31 | 36 | 39 | 42 | 57 | 74 |
| Profit before tax | 33 | 2 | 77 | 129 | 195 | 258 | 265 |
| Tax % | 10% | 248% | 34% | 43% | 10% | 25% | |
| 30 | -2 | 51 | 73 | 177 | 194 | 199 | |
| EPS in Rs | 5.83 | -0.45 | 10.05 | 12.90 | 26.94 | 29.51 | 30.27 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 4% | 3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 20% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 44% |
| 3 Years: | 55% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 19% |
| Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 57 | 66 | 66 | 66 |
| Reserves | 186 | 188 | 243 | 309 | 1,103 | 1,291 | 1,385 |
| 272 | 426 | 495 | 469 | 0 | 393 | 403 | |
| 94 | 124 | 120 | 151 | 112 | 155 | 168 | |
| Total Liabilities | 603 | 789 | 909 | 986 | 1,281 | 1,905 | 2,023 |
| 435 | 630 | 684 | 720 | 718 | 977 | 998 | |
| CWIP | 10 | 26 | 27 | 29 | 74 | 185 | 296 |
| Investments | 2 | 7 | 3 | 2 | 17 | 114 | 526 |
| 156 | 126 | 195 | 235 | 473 | 628 | 203 | |
| Total Assets | 603 | 789 | 909 | 986 | 1,281 | 1,905 | 2,023 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 74 | 123 | 137 | 117 | 115 | 253 | |
| -43 | -295 | -84 | -104 | -246 | -209 | |
| -32 | 184 | 32 | 18 | 128 | 301 | |
| Net Cash Flow | -1 | 12 | 85 | 31 | -3 | 345 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 35 | 16 | 14 | 19 | 19 | 12 |
| Inventory Days | 64 | 48 | 39 | 44 | 41 | 38 |
| Days Payable | 268 | 217 | 157 | 164 | 120 | 163 |
| Cash Conversion Cycle | -169 | -152 | -104 | -101 | -59 | -113 |
| Working Capital Days | 17 | -7 | -24 | -24 | -5 | -20 |
| ROCE % | 7% | 17% | 21% | 22% | 18% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7h - Of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2025.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
2d - Investor Presentation for the quarter and half year ended September 30, 2025
- Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2025 2d
-
Board Meeting Outcome for Outcome Of Board Meeting Dated November 07, 2025
2d - Unaudited standalone and consolidated results for quarter and half-year ended Sept 30, 2025 approved; limited review unmodified.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 Nov - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Oct 2023TranscriptNotesPPT
Hospital Portfolio[1][2]
The company operates 3 hospitals with 1,275 Doctors across:
a) Thane - 377 Operating Beds and 72.1% Average Occupancy
b) Pune - 309 Operating Beds and 54.9% Average Occupancy
c) Indore - 375 Operating Beds and 65.5% Average Occupancy